Compare Stocks: ATPC, MTEX, DRMA, and SNYR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATPC Agape ATP	$2.50 -3.5%	$3.04	$1.72 ▼ $73.50	$2.59M	0.38	2.58 million shs	109,242 shs
DRMA Dermata Therapeutics	$1.17 +6.4%	$1.26	$0.95 ▼ $6.99	$4.42M	0.66	61,157 shs	64,213 shs
MTEX Mannatech	$5.07	$5.14	$3.80 ▼ $12.45	$9.78M	0.73	10,110 shs	6,710 shs
SNYR Synergy CHC	$0.17 -3.3%	$0.20	$0.16 ▼ $3.99	$2.64M	-0.14	186,071 shs	367,794 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATPC Agape ATP	-1.69%	+9.17%	-12.59%	-6.02%	-96.45%
DRMA Dermata Therapeutics	+5.60%	-0.85%	-12.69%	-10.00%	-82.69%
MTEX Mannatech	0.00%	+5.19%	+0.60%	+8.57%	-36.55%
SNYR Synergy CHC	-3.31%	-0.70%	-19.24%	-57.13%	-95.26%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATPC Agape ATP	$2.50 -3.5%	$3.04	$1.72 ▼ $73.50	$2.59M	0.38	2.58 million shs	109,242 shs
DRMA Dermata Therapeutics	$1.17 +6.4%	$1.26	$0.95 ▼ $6.99	$4.42M	0.66	61,157 shs	64,213 shs
MTEX Mannatech	$5.07	$5.14	$3.80 ▼ $12.45	$9.78M	0.73	10,110 shs	6,710 shs
SNYR Synergy CHC	$0.17 -3.3%	$0.20	$0.16 ▼ $3.99	$2.64M	-0.14	186,071 shs	367,794 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATPC Agape ATP	-1.69%	+9.17%	-12.59%	-6.02%	-96.45%
DRMA Dermata Therapeutics	+5.60%	-0.85%	-12.69%	-10.00%	-82.69%
MTEX Mannatech	0.00%	+5.19%	+0.60%	+8.57%	-36.55%
SNYR Synergy CHC	-3.31%	-0.70%	-19.24%	-57.13%	-95.26%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATPC Agape ATP	1.00	Sell	N/A	N/A
DRMA Dermata Therapeutics	2.00	Hold	$10.00	754.70% Upside
MTEX Mannatech	1.00	Sell	N/A	N/A
SNYR Synergy CHC	2.00	Hold	$6.25	3,585.14% Upside

Current Analyst Ratings Breakdown

Latest ATPC, MTEX, DRMA, and SNYR Analyst Ratings

Date	Company	Brokerage	Action	Rating
7/28/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/17/2026	MTEX Mannatech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/10/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
7/1/2026	MTEX Mannatech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/29/2026	SNYR Synergy CHC	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/23/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
6/12/2026	SNYR Synergy CHC	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
6/11/2026	MTEX Mannatech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/11/2026	SNYR Synergy CHC	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/4/2026	DRMA Dermata Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
5/26/2026	MTEX Mannatech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATPC Agape ATP	$1.52M	1.64	N/A	N/A	$22.41 per share	0.11
DRMA Dermata Therapeutics	N/A	N/A	N/A	N/A	$2.19 per share	N/A
MTEX Mannatech	$108.04M	0.09	N/A	N/A	($2.75) per share	-1.84
SNYR Synergy CHC	$30.38M	0.08	N/A	N/A	($2.06) per share	-0.08

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATPC Agape ATP	-$2.28M	-$1.33	N/A	N/A	N/A	-125.89%	-8.43%	-7.75%	N/A
DRMA Dermata Therapeutics	-$7.56M	-$5.31	N/A	N/A	N/A	N/A	-127.91%	-105.05%	8/18/2026 (Estimated)
MTEX Mannatech	-$15.21M	-$6.71	N/A	N/A	N/A	-11.97%	-2,383.34%	-40.24%	N/A
SNYR Synergy CHC	-$12.34M	-$1.40	N/A	1.13	N/A	-60.02%	N/A	-30.30%	N/A

Latest ATPC, MTEX, DRMA, and SNYR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	DRMA Dermata Therapeutics	-$0.55	N/A	N/A	N/A	N/A	N/A
5/15/2026	Q1 2026	ATPC Agape ATP	N/A	-$0.33	N/A	-$0.33	N/A	$0.27 million
5/14/2026	Q4 2025	MTEX Mannatech	N/A	$0.49	N/A	$0.49	N/A	$24.92 million
5/14/2026	Q1 2026	SNYR Synergy CHC	$0.03	-$0.23	-$0.26	-$0.23	N/A	$5.49 million
5/13/2026	Q1 2026	DRMA Dermata Therapeutics	-$0.53	-$0.48	+$0.05	-$0.48	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATPC Agape ATP	N/A	N/A	N/A	N/A	N/A
DRMA Dermata Therapeutics	N/A	N/A	N/A	N/A	N/A
MTEX Mannatech	N/A	N/A	-100.00%	N/A	N/A
SNYR Synergy CHC	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATPC Agape ATP	N/A	9.01	9.01
DRMA Dermata Therapeutics	N/A	7.09	7.00
MTEX Mannatech	N/A	1.09	0.59
SNYR Synergy CHC	N/A	0.93	0.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATPC Agape ATP	0.01%
DRMA Dermata Therapeutics	8.67%
MTEX Mannatech	12.98%
SNYR Synergy CHC	N/A

Insider Ownership

Company	Insider Ownership
ATPC Agape ATP	2.04%
DRMA Dermata Therapeutics	21.90%
MTEX Mannatech	47.50%
SNYR Synergy CHC	32.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATPC Agape ATP	40	1.00 million	981,000	Not Optionable
DRMA Dermata Therapeutics	8	4.02 million	3.14 million	Not Optionable
MTEX Mannatech	250	1.93 million	1.01 million	Not Optionable
SNYR Synergy CHC	40	15.08 million	10.12 million	N/A

ATPC, MTEX, DRMA, and SNYR Headlines

Recent News About These Companies

Synergy CHC Corporate Event Calendar | NASDAQ:SNYR

July 15, 2026 | benzinga.com

Synergy CHC Corp. (SNYR) Shareholder/Analyst Call Prepared Remarks Transcript

June 29, 2026 | seekingalpha.com

Synergy CHC (SNYR) Stock Fair Value Falls As Analysts Turn More Cautious

June 27, 2026 | finance.yahoo.com

Synergy CHC Corp. Stock Short Interest Rises to 42.12%

June 10, 2026 | quiverquant.comQ

Synergy CHC (SNYR)

May 30, 2026 | invezz.comI

Synergy CHC Corp SNYR

May 19, 2026 | morningstar.comM

Synergy CHC Receives Nasdaq Minimum Bid Price Notice

May 18, 2026 | tipranks.com

Synergy Hesitates on Quarterly Numbers

May 15, 2026 | baystreet.ca

Synergy CHC Corp. (SNYR) Reports Q1 Loss, Misses Revenue Estimates

May 14, 2026 | zacks.com

Synergy CHC Corp. Reports First Quarter 2026 Financial Results

May 14, 2026 | globenewswire.com

Synergy CHC Establishes Equity Line Financing Agreement

May 11, 2026 | tipranks.com

Synergy CHC Corp. Stock Short Interest Rises to 35.83%

May 5, 2026 | quiverquant.comQ

Synergy CHC Corp. (NASDAQ:SNYR) Short Interest Up 3,525.7% in April

April 25, 2026 | defenseworld.netD

Synergy CHC shares surge nearly 100% in after-hours trading: What's going on?

April 14, 2026 | msn.com

Synergy CHC Corp. (NASDAQ:SNYR) Q4 2025 Earnings Call Transcript

April 3, 2026 | insidermonkey.com

Synergy CHC Corp (SNYR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing ...

April 1, 2026 | finance.yahoo.com

Synergy CHC Corp. (SNYR) Q4 2025 Earnings Call Transcript

April 1, 2026 | seekingalpha.com

Synergy CHC delays annual Form 10-K filing

April 1, 2026 | tipranks.com

Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results

April 1, 2026 | globenewswire.com

Synergy CHC Corp. Announces New Release Date for Fourth Quarter and Full Year 2025 Financial Results

March 30, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC, MTEX, DRMA, and SNYR Company Descriptions

Agape ATP NASDAQ:ATPC

$2.50 -0.09 (-3.47%)

Closing price 08/5/2026 04:00 PM Eastern

Extended Trading

$2.38 -0.12 (-4.80%)

As of 05:00 AM Eastern

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Dermata Therapeutics NASDAQ:DRMA

$1.17 +0.07 (+6.36%)

Closing price 08/5/2026 04:00 PM Eastern

Extended Trading

$1.23 +0.06 (+4.70%)

As of 08/5/2026 07:58 PM Eastern

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Mannatech NASDAQ:MTEX

$5.07 0.00 (0.00%)

As of 08/4/2026 04:00 PM Eastern

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Synergy CHC NASDAQ:SNYR

$0.17 -0.01 (-3.31%)

As of 08/5/2026 04:00 PM Eastern

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ATPC, MTEX, DRMA, and SNYR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ATPC, MTEX, DRMA, and SNYR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ATPC, MTEX, DRMA, and SNYR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC, MTEX, DRMA, and SNYR Company Descriptions

Agape ATP NASDAQ:ATPC

Dermata Therapeutics NASDAQ:DRMA

Mannatech NASDAQ:MTEX

Synergy CHC NASDAQ:SNYR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ATPC, MTEX, DRMA, and SNYR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ATPC, MTEX, DRMA, and SNYR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ATPC, MTEX, DRMA, and SNYR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC, MTEX, DRMA, and SNYR Company Descriptions

Agape ATP NASDAQ:ATPC

Dermata Therapeutics NASDAQ:DRMA

Mannatech NASDAQ:MTEX

Synergy CHC NASDAQ:SNYR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools